September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
WASHINGTON — Pharmacy is helping solve the “cost-quality-access conundrum” facing health care, says CVS Health president and chief executive officer Larry Merlo. “Pharmacy is extending the front lines of health care to deliver better outcomes more affordably to the people that we serve,” Merlo said this month at the National Press Club. Contending that the
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
DEERFIELD, Ill. — Walgreen Co. continues to move ahead with its planned acquisition of Alliance Boots GmbH. The company has filed documents with the Securities and Exchange Commission for the creation of a new holding company, Walgreens Boots Alliance Inc., which will be legally based in Delaware. Deerfield, Ill.-based Walgreen Co. and Bern, Switzerland-based Alliance
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
BOISE, Idaho — AB Acquisition LLC (Albertsons) and Safeway Inc. have chosen the leadership team that will head the combined supermarket company when its planned merger is completed. “We’re drawing on the strong talent within both companies to build an innovative, customer-focused and growth-driven company,” said Safeway president and chief executive officer Robert Edwards, who
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
BENTONVILLE, Ark. — Walmart is rebranding its Walmart Express store format to Walmart Neighborhood Market. That means the 21 Walmart Express stores now in business and others in development will become Neighborhood Markets. The change was announced earlier this month. Walmart has 346 Neighborhood Markets, all of which have pharmacies and are typically 38,000 square
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
SEATTLE — Pharmaca Integrative Pharmacy has debuted a store in Seattle’s Queen Anne neighborhood here, its fifth in Washington state. The new outlet offers a one-stop shopping experience for natural health and beauty products and services. “Seattle residents have already come to know and love Pharmaca’s unique shopping experience, so we’re excited to be able
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
WASHINGTON — Legislation designed to combat the abuse of prescription medications has been introduced in the U.S. Senate, following passage of a similar bill in the House. The bill would establish a congressionally mandated report from the Department of Health and Human Services, which would be required to seek input from the Drug Enforcement Administration
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
ATLANTA — Home Depot Inc. said that the malware hackers used to steal an estimated 56 million debit and credit card numbers from its customers in the United States and Canada between April and earlier this month has been eliminated from its store networks, closing off the cyberthieves’ point of entry. The scale of the
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
MATTHEWS, N.C. — The directors of Family Dollar Stores Inc. continue to back Dollar Tree Stores Inc.’s bid to acquire their company, despite Dollar General Corp.’s higher offer. Dollar General has made a hostile bid for its dollar store rival. It has offered $80 per share, or $9.1 billion. That compares to Dollar Tree’s acquisition
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, News
WOONSOCKET, R.I. — CVS Health has hired Mary Langowski as executive vice president for strategy, policy and market development, effective October 14. Langowski will focus on identifying and expanding enterprise opportunities as the company seeks an increasingly prominent role in the health care system, CVS says. Langowski is coming to CVS from DLA Piper, where
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, Opinion
In a year crammed with major news stories, cataclysmic personnel shifts and stunning new strategies and directions, the No. 1 retailing story of 2014 increasingly appears to be the CVS decision, announced early this year, to stop selling tobacco products in its 7,700 drug stores. What continues to stamp this decision and its aftermath as
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, Opinion
October 1 is the first anniversary of the debut of the federal and state health care exchanges that allow Americans to assess insurance options and purchase coverage under the Affordable Care Act. Since then 7.3 million people have signed up, and another 4.8 million have obtained access to health care through the expansion of Medicaid.
September 25, 2014 by Chain Drug Review
Issue 09-29-2014, Opinion
When President Ronald Reagan signed the Drug Price Competition and Patent Term Restoration Act 30 years ago, few could imagine how the law would transform the health care landscape. Today, we know that this landmark “Hatch-Waxman” legislation is responsible for improving the lives of millions of Americans by creating a new framework allowing safe, affordable
September 25, 2014 by Michael Wise, Vishal Bhandari, Kelsey Christian and Chain Drug Review
A.T. Kearney, Big Pharma, direct delivery, direct-to-consumer, health care delivery, Kelsey Christian, Michael Wise, pharmaceutical manufacturers, retail pharmacy, Vishal Bhandari
Issue 09-29-2014, Opinion
Are we seeing the first early “green shoots” of a new industry disruptor? Possibly. Big Pharma has started experimenting with direct-to-consumer models to fill prescriptions, effectively circumventing the retail pharmacy. Is the position of neighborhood pharmacies in today’s delivery system secure, or could the pharmacy suffer the same fate as the corner bookstore, replaced by
September 25, 2014 by Chain Drug Review
Retail News
Pharmacists Perform Health Screenings on Capitol Hill to Demonstrate Patient Care Services Share This Page Share on facebook Share on twitter Share on email Share on print September 18, 2014 Event brings pharmacist-provided patient care services directly to some of our nation’s key decision makers. Advertisement WASHINGTON, DC – Yesterday, more than 50 DC-area pharmacists